Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
- Lilly: 2 events in the last 90 days
- Previous: 6 days earlier · Novartis heart drug's trial failure cast doubt on Amgen and Lilly's cholesterol race
What happened
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
Summary assembled by rule from the sources below